On Monday, Catheter Precision Inc (AMEX: VTAK) opened higher 0.39% from the last session, before settling in for the closing price of $0.51. Price fluctuations for VTAK have ranged from $0.31 to $8.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 569.59% over the past five years. With a float of $2.41 million, this company’s outstanding shares have now reached $2.80 million.
Let’s look at the performance matrix of the company that is accounted for 14 employees. In terms of profitability, gross margin is -25.92%, operating margin of -2444.95%, and the pretax margin is -2176.83%.
Catheter Precision Inc (VTAK) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Catheter Precision Inc is 14.18%, while institutional ownership is 2.54%. The most recent insider transaction that took place on Jan 23 ’24, was worth 5,694. In this transaction Executive Chairman and CEO of this company bought 9,528 shares at a rate of $0.60, taking the stock ownership to the 329,856 shares. Before that another transaction happened on Jan 22 ’24, when Company’s Executive Chairman and CEO bought 9,528 for $0.43, making the entire transaction worth $4,092. This insider now owns 320,328 shares in total.
Catheter Precision Inc (VTAK) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -11.5 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -3.02) by -8.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Catheter Precision Inc (AMEX: VTAK) Trading Performance Indicators
Check out the current performance indicators for Catheter Precision Inc (VTAK). In the past quarter, the stock posted a quick ratio of 0.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.96
Technical Analysis of Catheter Precision Inc (VTAK)
Catheter Precision Inc (AMEX: VTAK) saw its 5-day average volume 0.75 million, a negative change from its year-to-date volume of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 6.59%. Additionally, its Average True Range was 0.14.
During the past 100 days, Catheter Precision Inc’s (VTAK) raw stochastic average was set at 2.46%, which indicates a significant decrease from 10.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 356.39% in the past 14 days, which was higher than the 234.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5853, while its 200-day Moving Average is $3.4610. Nevertheless, the first resistance level for the watch stands at $0.5900 in the near term. At $0.6700, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7200. If the price goes on to break the first support level at $0.4600, it is likely to go to the next support level at $0.4100. The third support level lies at $0.3300 if the price breaches the second support level.
Catheter Precision Inc (AMEX: VTAK) Key Stats
There are currently 989K shares outstanding in the company with a market cap of 1.48 million. Presently, the company’s annual sales total 440 K according to its annual income of -70,570 K. Last quarter, the company’s sales amounted to 90 K and its income totaled -4,220 K.